PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBWith the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates thorough preparation …
Sanofi/Regeneron’s Dupixent approved by FDA to treat …
WEB1 day ago · Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD). The regulator’s decision, which makes Dupixent the first biologic medicines approved in the US for COPD ...
FDA approves updated COVID-19 vaccines to better protect …
WEBAug 23, 2024 · The US Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna to better protect against currently circulating variants.
Keytruda gains eighth FDA approval this year - PMLiVE
WEBDec 7, 2021 · 2021 has been a good year for Keytruda (pembrolizumab), which has notched up more than 20 approvals across the world and is on track to bring in at least £17bn for Merck – known as MSD outside the US and Canada – this year alone.
PME - Home
WEBHow AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate.
PME - PMLiVE
WEBPharmaceutical Market Europe – December 2023. Full coverage of the 23rd annual PMEAs; Virtual patient care – a glimpses of an exciting future; Rare diseases – the importance of screening for SMA
UPDATED: BMS completes Celgene merger after FTC okay
WEBNov 18, 2019 · After US regulators finally gave their blessing for Bristol-Myers Squibb’s $74bn takeover of Celgene, the acquisition was finally completed on 20 November.
AstraZeneca presents positive phase 3 results for Imfinzi ... - PMLiVE
WEBAstraZeneca’s (AZ) Imfinzi has shown promising results when used before and after surgery in resectable early-stage non-small cell lung cancer (NSCLC), according to new phase 3 …
Sales Archives - PMLiVE
WEBThe companies will use Genetic Leap’s AI platform to generate oligonucleotide drugs against targets selected by Lilly. Read More
Communique - PMLiVE
WEBCommuniqué – Volume 53. New insights in health comms innovation. Communiqué Awards 2022 – winners’ case studies. INSIGHTS – Demonstrating impact • Driving behaviour change